Clinical Trials Logo

Pontine Hemorrhage clinical trials

View clinical trials related to Pontine Hemorrhage.

Filter by:
  • None
  • Page 1

NCT ID: NCT04647162 Recruiting - Surgery Clinical Trials

A Clinical Trial About the Safety of Surgical Treatment in Severe Primary Pontine Hemorrhage

STIPE
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Primary pontine hemorrhage (PPH) is not common but is the most catastrophic subtype of intracerebral hemorrhage, with acute mortality between 30% and 60%. For severe PPH, defined as Glasgow Coma score (GCS) <8 and hematoma volumeā‰„5ml, the mortality rate is as high as 80-100%. Guidelines from the American Heart Association and European Stroke Organization do not make definite specifications. More than a century after Finkelnburg first explored the brainstem for hematoma, however, plenty of researches have shown surgery can save lives and improve the prognosis for selective patients and can be an effective and safe treatment. This study is proposed to validate the safety of surgical treatment in severe primary pontine hemorrhage.